Q2 2026 13F · SEC CIK 1696802

Forefront Analytics, LLC

Institutional asset managerFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $92.0M
Reported positions: 37
Top holdings a year, 3 yrs: +17.0%
Assets under management: $679.0M

Forefront Analytics, LLC is an institutional asset manager that reported 37 positions worth $92.0M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Vanguard Intl Equity Index F (VWO, 11.7%), iShares ESG Aware MSCI EAFE ETF (ESGD, 11.6%), iShares ESG Aware MSCI EM ETF (ESGE, 11.4%). A portfolio copying its top holdings returned 17.0% a year over the last 3 years, against 22.3% for the S&P 500.

Forefront Analytics, LLC holdings all 37 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Forefront Analytics, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
VWOVanguard Intl Equity Index F	11.7%	8.9%	180,376	+0.1%	$10.8M
ESGDiShares ESG Aware MSCI EAFE ETF	11.6%	22.1%	104,247	-59.0%	$10.7M
ESGEiShares ESG Aware MSCI EM ETF	11.4%	15.3%	192,398	-47.9%	$10.5M
HDVIshares Tr	10.2%	8.4%	342,756	+403.4%	$9.4M
MTUMIshares Tr	9.1%	5.3%	24,434	+0.8%	$8.4M
NULVNushares ETF Tr	7.7%	8.1%	140,912	-28.0%	$7.0M
DBEFDbx ETF Tr	7.5%	5.7%	126,734	-0.1%	$6.9M
ESGGFlexshares Tr	5.5%	8.0%	21,669	-51.0%	$5.1M
NVDANvidia Corporation	4.2%	2.3%	19,532	+37.2%	$3.9M
VEAVanguard Ftse Developed Markets Index Fu	3.7%	2.8%	47,559	+0.5%	$3.4M
IVVIshares Tr	3.6%	2.7%	4,450	-0.5%	$3.3M
HEEMIshares Inc	2.8%	2.0%	58,203	-0.6%	$2.6M
JPMJpmorgan Chase & Co	1.8%	1.3%	4,997	+0.3%	$1.6M
DEDeere & Co	0.8%	0.6%	1,172	+3.2%	$743K
UNHUnitedhealth Group Inc	0.6%	0.5%	1,409	-28.9%	$586K
INCYIncyte Corp	0.6%	0.4%	5,091	+20.3%	$577K
EWEdwards Lifesciences Corp	0.6%	0.5%	6,158	-6.3%	$557K
SSOProshares Tr	0.6%	0.4%	8,180	+0.2%	$551K
UWMProshares Tr	0.6%	0.3%	7,997	+0.1%	$538K
ABTAbbott Laboratories	0.6%	0.5%	5,665	+12.3%	$514K
EESWisdomtree Tr	0.5%	0.4%	7,020	-14.7%	$476K
PFEPfizer Inc	0.5%	0.3%	18,210	+39.1%	$438K
MDTMedtronic PLC	0.5%	0.4%	5,319	+0.0%	$416K
DHRDanaher Corp Del	0.4%	0.2%	2,040	+58.4%	$389K
TMOThermo Fisher Scientific Inc	0.4%	0.3%	669	+15.5%	$336K
OTFBlue Owl Technology Finance	0.3%	0.3%	29,654	+0.0%	$307K
LEGNLegend Biotech Corp	0.3%	0.3%	10,568	-32.5%	$305K
PMPhilip Morris Intl Inc	0.3%	0.2%	1,463	+0.9%	$265K
REGNRegeneron Pharmaceuticals	0.3%	0.3%	415	-9.8%	$259K
SCHDSchwab Strategic Tr	0.3%	0.4%	7,676	-49.2%	$243K
VTVVanguard Index Fds	0.3%	0.2%	1,084	-17.7%	$236K
ZURAZura Bio Ltd	0.2%	0.1%	26,968	+81.0%	$159K
GERNGeron Corp	0.1%	0.1%	88,779	+61.1%	$114K
CTMXCytomx Therapeutics Inc.	0.1%	0.1%	25,033	+100.6%	$94K
BCYCBicycle Therapeutics PLC	0.1%	0.1%	21,822	+51.6%	$93K
NKTXNkarta Inc	0.1%	0.1%	28,955	-33.9%	$82K
ANNXAnnexon Inc	0.1%	0.1%	14,240	+0.0%	$81K

What Forefront Analytics, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

No new positions among the largest holdings.

Share counts compared with the Q1 2026 13F; a split also changes share counts.

How the holdings did against the S&P 500.

1 year: +14.2% /yr; S&P 500 +11.7%
3 years: +17.0% /yr; S&P 500 +22.3%
5 years: +4.0% /yr; S&P 500 +10.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$92.0M	37
Q1 2026	$110.0M	39
Q4 2025	$113.3M	43
Q3 2025	$103.8M	43
Q2 2025	$89.5M	43
Q1 2025	$86.9M	45
Q4 2024	$215.0M	64
Q3 2024	$212.0M	67
Q2 2024	$208.9M	68
Q1 2024	$206.2M	67
Q4 2023	$202.6M	67
Q3 2023	$176.3M	67

Questions about Forefront Analytics, LLC's portfolio

What stocks does Forefront Analytics, LLC own?

Forefront Analytics, LLC's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 37 positions worth $92.0M. The largest are Vanguard Intl Equity Index F (VWO) at 11.7%, iShares ESG Aware MSCI EAFE ETF (ESGD) at 11.6%, iShares ESG Aware MSCI EM ETF (ESGE) at 11.4%, Ishares Tr (HDV) at 10.2% and Ishares Tr (MTUM) at 9.1%.

What did Forefront Analytics, LLC buy last quarter?

In Q2 2026, Forefront Analytics, LLC added Ishares Tr (HDV) (+403.4% shares), Cytomx Therapeutics Inc. (CTMX) (+100.6% shares) and Zura Bio Ltd (ZURA) (+81.0% shares), compared with its Q1 2026 filing.

What did Forefront Analytics, LLC sell last quarter?

In Q2 2026, Forefront Analytics, LLC sold all of Dimensional US Small Cap (DFSV), sold all of Mereo Biopharma Group PLC (MREO), iShares ESG Aware MSCI EAFE ETF (ESGD) (-59.0% shares), Flexshares Tr (ESGG) (-51.0% shares) and Schwab Strategic Tr (SCHD) (-49.2% shares), compared with its Q1 2026 filing.

How has Forefront Analytics, LLC's portfolio performed?

A portfolio copying Forefront Analytics, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +17.0% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +14.2% against +11.7%. Over 5 years: +4.0% a year against +10.6%.

When is Forefront Analytics, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Forefront Analytics, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Forefront Analytics, LLC manage?

Forefront Analytics, LLC reported $679.0M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $92.0M.